Nevertheless, both KRAS and NRAS MAF displayed a poor diagnostic performance in identifying patients with liver and lung metastasis, respectively, and their potential role as a diagnostic biomarker for early detection of metastasis in CRC patients is unclear. This evidence concerns the gene KRAS and colorectal carcinoma.